| New This Week on Process Development Forum |
| |
- A Successful First Year for Testa Center
The bioprocess pilot-scale facility in Uppsala, Sweden, has hosted 15 national and international projects and more than 2000 study visits since its opening in 2018.
(Read Article)
|
-
Driving Improved Access to Biosimilars
New guidance from FDA, including standards for interchangeability, is expected to speed development of biosimilars, but experts warn against oversimplifying risk to reduce costs.
(Read Article)
|
- How to Adapt Biomanufacturing Processes
As the need for more complex molecules drives a new era of biomanufacturing, there is an increased focus on developing processes with improved security, yield, and process economy.
(Read Article)
|
- GE Healthcare and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing
GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, are combining their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.
(Read Article)
|
| Process Development Forum Topic Spotlight |
| |
|
|
|
|
| |
GO TO: Process Development Forum
Join the Conversation on LinkedIn |
|
|
|
Questions for 2020
Like what you read? Want to see more of something in particular? Let us know what topics are on your mind and what you'd like to see more of in 2020. |
 |
|
|
